Search results for "Mucocutaneous zone"

showing 10 items of 30 documents

Hydroxyurea‑induced superinfected ulcerations: Two case reports and review of the literature

2020

The chronic use of hydroxyurea (HU) in some oncologic and non-oncologic diseases (psoriasis, sickle cell anemia) can be accompanied by side effects, both systemic and mucocutaneous. The most severe adverse events known in HU therapy are leg ulcers and cutaneous carcinomas. At skin level may also appear: xerosis, persistent pruritus, skin color changes (erythema, hyperpigmentation), cutaneous atrophy. Likewise, oral ulcerations and stomatitis may occur at mucosal level. Hair damage can be expressed through alopecia and nail damage through melanonychia and oncycholysis. First case, a 63-year-old woman with severe psoriasis vulgaris and chronic granulocytic leukemia, with 5 years of HU therapy…

0301 basic medicineCancer Researchmedicine.medical_specialtyErythemaMucocutaneous zoneleg ulcersmedicine.disease_causehydroxyurea03 medical and health sciences0302 clinical medicineImmunology and Microbiology (miscellaneous)PsoriasismedicineStomatitiscutaneousbusiness.industrysuperinfectedArticlesGeneral Medicinemedicine.diseaseHyperpigmentationDermatologyside effects030104 developmental biologyMelanonychia030220 oncology & carcinogenesisCellulitisSuperinfectionmedicine.symptombusinessExperimental and Therapeutic Medicine
researchProduct

Langerhans Cells Suppress CD8+ T Cells In Situ during Mucocutaneous Acute Graft-Versus-Host Disease

2021

Acute graft-versus-host disease (aGVHD) induced by allogenic hematopoietic stem cell transplantation is an immunological disorder in which donor lymphocytes attack recipient organs. It has been proven that recipient nonhematopoietic tissue cells, such as keratinocytes, are sufficient as immunological targets for allogenic donor T cells, whereas Langerhans cells (LCs) are potent professional hematopoietic antigen-presenting cells existing in the target epidermis and eliminated during the early phase of mucocutaneous aGVHD. Moreover, LCs have been reported to negatively regulate various types of immune responses. Here, we present data showing that initial depletion of recipient LCs exacerbate…

0301 basic medicineLangerhans cellintegumentary systemRegulatory T cellMucocutaneous zoneCell BiologyDermatologyDendritic cellBiologyBiochemistry03 medical and health sciencesHaematopoiesis030104 developmental biology0302 clinical medicinemedicine.anatomical_structureImmune system030220 oncology & carcinogenesisCancer researchmedicineCytotoxic T cellBone marrowMolecular BiologyJournal of Investigative Dermatology
researchProduct

AB0492 INTESTINAL MICROBIOTA COMPOSITION OF PATIENT’S WITH BEHCET’S DISEASE: DIFFERENCES BETWEEN EYE, MUCOCUTANEOUS AND VASCULAR INVOLVEMENT (RHEUMA-…

2020

Background:Recently, it has been shown that changes in microbiota composition play a role in the etiology and pathogenesis of chronic diseases. Changes in oral and intestinal microbiota diversity and composition are suggested in Behcet disease (BD), however there are no study available about the potential gut microbiota changes among different clinical forms of BD.Objectives:The aim of this study was to evaluate the intestinal microbiota composition of patient with BD and healthy controls, and also compare BD patients regarding to their eye, mucocutaneous and vascular involvement.Methods:In this prospective cohort study,27 patients diagnosed with BD and 10 aged and sex matched healthy contr…

0301 basic medicinemedicine.medical_specialtyImmunologyMucocutaneous zoneEggerthella lentaBehcet's diseaseGut floraSutterellaGastroenterologyGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineRheumatologyInternal medicinemedicineImmunology and Allergy030203 arthritis & rheumatologybiologybusiness.industryAkkermansiabiology.organism_classificationmedicine.disease030104 developmental biologybusinessActinomycesEggerthellaAnnals of the Rheumatic Diseases
researchProduct

Epstein-Barr virus is not detected in mucosal lichen planus

2018

Background Lichen planus (LP) is a chronic inflammatory, immunological, mucocutaneous disease can affect skin, genital and oral mucosa. Oral lichen planus (OLP) is the most common noninfectious, chronic inflammatory oral disease affecting 1-2% of the general adult population. World Health Organization (WHO) classifies OLP as a potentially malignant disorder. Epstein Barr virus or human herpesvirus-4, is a member of the herpes virus family and one of the most ubiquitous viruses known to human, infecting approximately 90% of the world’s adult population. The virus often infects B lymphocytes resulting in a wide spectrum of mucocutaneous and systemic diseases, ranging from mild lesions to aggr…

AdultMaleHerpesvirus 4 Humanmedicine.medical_specialtyMucocutaneous zonemedicine.disease_causeYoung Adult03 medical and health sciences0302 clinical medicinestomatognathic systemmedicineHumansSex organOral mucosaskin and connective tissue diseasesGeneral DentistryAgedAged 80 and overOral Medicine and PathologyMucous Membraneintegumentary systembusiness.industryResearchLichen Planusfood and beveragesMucous membrane030206 dentistryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseEpstein–Barr virusDermatologystomatognathic diseasesmedicine.anatomical_structureOtorhinolaryngology030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASFemaleSurgeryOral lichen planusbusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Epidemiology of desquamative gingivitis: evaluation of 125 patients and review of the literature

2009

Background  Desquamative gingivitis (DG) is a descriptive term used to indicate epithelial desquamation, erythema, erosions, and/or vesiculobullous lesions of the gingiva. DG is commonly associated with several mucocutaneous disorders and systemic conditions that may carry a poor prognosis and high morbidity; however, there are no clear data concerning the frequency of these disease associations. Methods  We investigated the epidemiologic features of DG in 125 patients and compared our findings with information from a literature review. Results  In our series, 88% of patients with DG had one of the following three disorders: oral lichen planus (OLP), mucous membrane pemphigoid (MMP), or pem…

AdultMalePathologymedicine.medical_specialtyErythemaAdolescentMucocutaneous zoneDermatologyGingivitisYoung AdultSettore MED/28 - Malattie OdontostomatologicheEpidemiologymedicineHumansSex organepidemiology desquamative gingivitisAgedAged 80 and overbusiness.industryPemphigus vulgarisMiddle Agedmedicine.diseaseDermatologyGingivitisDesquamative gingivitisstomatognathic diseasesOral lichen planusFemalemedicine.symptombusiness
researchProduct

Uncommon oral manifestation of lichen sclerosus: critical analysis of cases reported from 1957 to 2016

2017

Background Lichen sclerosus is a mucocutaneous autoimmune disease which might be initiated by infectious pathogens as Borrelia Bugrdorferi and HPV. This disease shows destructive potential and is rarely diagnosed in oral mucosa. The purpose of this paper is to evaluate the characteristics of cases described in literature from 1957 to 2016, looking to provide valuable evidence about clinicopathologic features of this disease. Material and Methods A MedLine search was performed aiming to find oral lichen sclerosus cases in literature and discuss its demographical and pathological characteristics as well as treatment methods performed for these cases. Results 34 oral lichen sclerosus cases wit…

AdultMalemedicine.medical_specialtyTime FactorsAdolescentMucocutaneous zoneReviewDiseaseLichen sclerosusAsymptomaticYoung Adult030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinestomatognathic systemmedicineHumansOral mucosaYoung adultChildGeneral DentistryPathologicalAgedAutoimmune diseaseOral Medicine and Pathologyintegumentary systembusiness.industryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseDermatologystomatognathic diseasesLichen Sclerosus et Atrophicusmedicine.anatomical_structureOtorhinolaryngology030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASFemaleSurgerymedicine.symptomMouth DiseasesbusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Role of interleukin-4 in pathogenesis of oral lichen planus : a systematic review

2020

Background Oral lichen planus (OLP) is a premalignant mucocutaneous disease that affects 1-2% of the adult population. Immunological factor may act as etiological factor. The cellular immune cells such as T cells are important in pathogenesis of OLP. Interleukin-4 (IL-4) is secreted by T-helper 2 (Th2). Several studies have been carried out on the role of IL-4 in OLP. The aim of this study was to review the level of IL-4 in OLP, effective factors in the production of IL-4 and its role in the development of OLP. Material and Methods A search in PubMed was performed on the literature published from 2000 until august 2019 using the following keywords: “oral lichen planus” or “OLP” and “interle…

Adultmedicine.medical_specialtymedicine.medical_treatmentMucocutaneous zoneDiseaseReviewPathogenesisstomatognathic systemmedicineHumansGeneral DentistryInterleukin 4Oral Medicine and Pathologybusiness.industryCase-control studymedicine.disease:CIENCIAS MÉDICAS [UNESCO]Dermatologystomatognathic diseasesCytokineOtorhinolaryngologyCase-Control StudiesUNESCO::CIENCIAS MÉDICASEtiologyCytokinesSurgeryOral lichen planusInterleukin-4businessPrecancerous ConditionsLichen Planus Oral
researchProduct

Prevalence of vulval lichen planus in a cohort of women with oral lichen planus: an interdisciplinary study

2006

Summary Background  Lichen planus (LP) is a mucocutaneous inflammatory dermatosis that frequently involves the oral and genital mucosae. Patients with LP affecting these sites are often seen by oral medicine specialists or gynaecologists who work in isolation and depend heavily on histopathologists to help them in confirming the diagnosis. There are few studies in the literature combining the experiences of these specialists who share the care of patients with both oral and genital LP. Objectives  To estimate the prevalence of vulval LP (VLP) in a cohort of patients with histologically confirmed oral LP (OLP). Methods  The study group consisted of 42 women histologically diagnosed with OLP.…

Colposcopymedicine.medical_specialtyPathologymedicine.diagnostic_testbusiness.industryMucocutaneous zoneDermatologyLichen sclerosusmedicine.diseaseDermatologyVulvastomatognathic diseasesmedicine.anatomical_structureBiopsyOral and maxillofacial pathologyMedicineOral lichen planusbusinessOral medicineBritish Journal of Dermatology
researchProduct

In situ delivery of corticosteroids for treatment of oral diseases.

2017

In many mucocutaneous disorders, corticosteroids therapy is currently central. Systemic therapy is restricted to severe disorders whereas topical applications are considered as the first-line treatment. The oral cavity environment, the medication form and other factors related to the delivery method are key factors for the therapy efficiency and effectiveness. Current marketed medications are not able to avoid wrong drug exposure and scarce patients’ compliance. Innovative in situ delivery systems are able to prolong the drug retention time on the mucosa and to avoid the drawbacks of conventional formulations. This review is intended to give a general overview of oral mucocutaneous patholo…

Drugcorticosteroidmedicine.medical_specialtymedia_common.quotation_subjectMucocutaneous zonePharmaceutical ScienceOral cavitySystemic therapy03 medical and health sciences0302 clinical medicineDrug Delivery Systemsin situ deliveryAdrenal Cortex HormonesMedicineHumansoral diseaseIntensive care medicinemedia_commonWrong drugbusiness.industryMouth Mucosa030206 dentistrySurgeryKey factorsSettore CHIM/09 - Farmaceutico Tecnologico Applicativo030220 oncology & carcinogenesisbusinessMouth DiseasesRetention timeTherapeutic delivery
researchProduct

Can we compare haemophilia carriers with clotting factor deficiency to male patients with mild haemophilia?

2020

Introduction Certain haemophilia carriers demonstrate an increased bleeding tendency, mainly related to clotting factor deficiency. No study has so far formally compared the bleeding phenotype of women and girls with mild FVIII or FIX deficiency and associated management with that of male patients affected by mild haemophilia A and B. Material and methods We retrospectively evaluated 44 women and girls with mild FVIII or FIX deficiency (FVIII or FIX 0.05-0.5 IU/mL) and 77 male patients with mild haemophilia A or B and compared them with respect to clotting factor level, age at and trigger for diagnosis, as well as treatment modalities. Results After excluding gender-related haemorrhagic sym…

FVIIImild haemophiliaAdultMalePediatricsmedicine.medical_specialtycongenital hereditary and neonatal diseases and abnormalitiesHeterozygoteAdolescentMucocutaneous zonecarriersPlasma factorAge at diagnosis030204 cardiovascular system & hematologyHaemophiliaHemophilia AHemostatics03 medical and health sciencesYoung Adult0302 clinical medicinecarrierhemic and lymphatic diseasesmedicineHumansDeamino Arginine VasopressinClotting factor deficiencyChildGenetics (clinical)AgedClotting factorAged 80 and overbusiness.industryFIXHematologyGeneral MedicineMiddle Agedmedicine.diseaseBlood Coagulation Factorsbleeding phenotypebleeding phenotype carriers FIX FVIII mild haemophiliaMale patientChild PreschoolMild haemophilia AFemalebusiness030215 immunologyHaemophilia : the official journal of the World Federation of HemophiliaREFERENCES
researchProduct